Clinical Trial Update: BIBR 277 Capsules in Hypertensive Patients With Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for BIBR 277 capsules in hypertensive patients with nephropathy. The Boehringer Ingelheim study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Nephropathy

Drugs mentioned

• BIBR 277

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 2 | Status: COMPLETED